Medistim

3rd quarter financial report 2016 for Medistim ASA

Sales ended at MNOK 67.9 for the quarter (MNOK 61.6),

a 10.2 % growth. Sales as of September increased by

13.5 % and ended at MOK 200.6 (MNOK 176.8). The

revenue growth is driven by sales of own products and

currency neutral growth was 13.0 % for the quarter and

16.1 % YTD. Operating profit (EBIT) for the quarter

ended at MNOK 15.9 (MNOK 12.7). Operating profit as of

September ended at MNOK 46.6 (MNOK 34.3.) an increase

of 36.0 %.

The 3rd quarter was a new record quarter in the US

with a currency neutral growth of 14.9 %. Also a

strong sales of ultrasound imaging products in Asia

and Australia contributed to the growth in the 3rd

quarter.

Profit per share increased with 8.6 % for the quarter

and ended at NOK 0.62 (NOK 0.57). Accumulated profit

per share was NOK 1.83 (NOK 1.56).

AI Terminal